Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Formica Capital in connection with its acquisition of the Rototec Group, the biggest supplier of geoenergy solutions in Europe
Mandate

Vinge advises Formica Capital in connection with its acquisition of the Rototec Group, the biggest supplier of geoenergy solutions in Europe

November 25, 2021 M&A Banking and Finance

Vinge has advised Formica Capital in connection with its acquisition of all shares in the Rototec Group. Rototec is a market leader in the field of geoenergy solutions for medium and large sized properties and handles Europe’s largest fleet of drilling equipment for geoenergy issues in Finland, Sweden and Norway.

Vinge’s team mainly consisted of Magnus Pauli (M&A), Johanna Hamrefält (Project Manager, M&A), Alexander Lindeberg (IP), Adam Loewenstein (M&A), Malin Olsson (HR), Hanna Marberg (M&A) as well as Fabian Ekeblad (Banking & Finance) and Elin Samara (Banking & Finance). Krogerus Attorneys acted as local counsel in Finland with Advokatfirmaet Thommessen AS acting as local counsel in Norway.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026